CFR Pharmaceuticals

CFR Pharmaceuticals is a leading multinational pharmaceutical company operating in 15 countries in Latin America (primarily Chile, Peru, Argentina, and Colombia) and other emerging markets. Its business model focuses on the development, manufacturing, and commercialization of branded generic specialty products. The company manages its business units, including: Drugtech (neurology, psychiatry, and cardiology), Gynopharm (women's health), Recalcine (acute care areas), Biomedical Sciences (monoclonal antibodies and treatments related to transplantation, dialysis, oncology, and rheumatology), Compound Injectables (sterile injectable products and lyophilized forms for anesthesia, infectious diseases, cardiology, and intensive care); and more.